Indrayani Biotech, listed on the Bombay Stock Exchange, has seen its share price surge by more than 800% over the past five years, emerging as a multibagger stock in the pharmaceutical sector.
In recent weeks, Indrayani Biotech’s stock has rallied more than 10%. According to the BSE analytics, the shares have massive returns of 843.50 per cent in the last 5 years.
Related News |
'New York Is A Swing State': Vivek Ramaswamy's Last Pitch For Trump At MSG Rally
At the time of filing, the shares of Indrayani Biotech were trading at Rs 45. The 52 week high and low of the share is Rs 99.70 and Rs 35 respectively.
Recently, the company also clarified in a BSE filing that there is no pending material information affecting the company’s stock price or volume movement.
“We would like to further clarify that there is no pending material information/announcement to be made as of date which have a bearing on the price/volume movement of the Company or which requires disclosures in accordance with the regulatory requirements. We assume that the movement in the share price of the Company is purely market driven and the Company has no role to play in this regard,” Indrayani Biotech said in a BSE filing after stock exchanges sought clarification from the company on the share price movement.
Indrayani Biotech has adopted a strategic approach by acquiring medium and small enterprises (MSMEs) with specialised expertise, allowing it to scale rapidly and unlock untapped value.
(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. Times Now Digital suggests its readers/audience to consult their financial advisors before making any money related decisions.)